Medicare Negotiates Major Prescription Drug Price Cuts

New agreements on 10 costly medications promise significant savings for seniors and taxpayers starting in 2026.

Medicare will see price cuts ranging from 38% to 79% on 10 high-cost drugs.
The negotiations are expected to save $6 billion for Medicare and $1.5 billion in out-of-pocket costs for enrollees.
Savings will begin in 2026, with further drug price negotiations planned annually.
The Inflation Reduction Act enabled these negotiations, marking a significant policy shift.
Legal challenges from the pharmaceutical industry could impact the future of these savings.